Inflammation as a key mediator: linking triglyceride-glucose index to prognosis in non-muscle-invasive bladder cancer
These findings suggest that the TyG index could serve as a valuable tool for risk stratification and prognostic assessment in NMIBC. Its integration into clinical decision-making frameworks may improve personalised management strategies, particularly by targeting systemic inflammation as a modifiable factor.
Authors
- Wentao Xia
- Shan Jiang (ORCID: https://orcid.org/0000-0003-1015-1278)
- Xianfeng Shao
- Li Ding (ORCID: https://orcid.org/0000-0003-1561-0250)
- Kun Wang (ORCID: https://orcid.org/0000-0003-2513-768X)
- Li Chen (ORCID: https://orcid.org/0000-0001-7670-8062)
- Yan Zhang (ORCID: https://orcid.org/0000-0003-0159-9062)
- Junqi Wang (ORCID: https://orcid.org/0000-0001-5192-7234)
- Jiahao Wang (ORCID: https://orcid.org/0009-0009-2972-0638)
- Zixiang Li (ORCID: https://orcid.org/0000-0001-5993-0438)
- He Zhang (ORCID: https://orcid.org/0009-0001-1899-2402)
Institutions
- Xuzhou Medical College (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-05-23
- DOI
- https://doi.org/10.3389/fonc.2025.1545985
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.01